+
Site Tour

Search

Showing - of 444 results.

  • Patients who benefit

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure PATENT DUCTUS ARTERIOSUS (PDA) CLOSURE IN INFANTS Narrowing of the…

  • Amplatzer™ Duct Occluder

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER: FOR LARGE PDA CLOSURE

  • Amplatzer™ Duct Occluder II

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER II: VERSATILITY TO CONFORM TO A VARIETY OF PDAs

  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure Constriction of the ductus arteriosus is a critical step in postnatal circulatory…

  • Prevention

    PFO CLOSURE Closure of a PFO may prevent paradoxical embolism by preventing a venous thrombus from passing through the PFO and thereby reducing the risk of recurrent stroke. Evidence from the most…

  • LAAO Summit 2023

    ON DEMAND - LAAO SUMMIT 2023 12th Global Left Atrial Appendage Occlusion Summit SESSION 1: WHAT IS NEW? SESSION 2: ANATOMY & IMAGING SESSION 3: LIVE SESSION 4: TIPS & TRICKS SESSION 5:…

  • Clinical Data

    U.S. PIVOTAL TRIAL: LOWER RATES OF ADVERSE EVENTS VS SURGERY2 This study was conducted to determine the safety and efficacy of transcatheter ASD closure involving 442 device-closure patients and…

  • Clinical Data

    AMPLATZER™ MUSCULAR VSD OCCLUDER DEMONSTRATED CLOSURE SUCCESS IN PATIENTS WITH VSD The Amplatzer™ Muscular VSD Occluder was evaluated in a prospective, non-randomized, multi-center clinical study…

  • Patients who benefit

    Amplatzer™ Muscular VSD Occluders The Amplatzer™ Muscular VSD Occluder is indicated for use in patients with a complex VSD of significant size to warrant closure—large volume left-to-right shunt,…

  • Guidelines & Recommendations

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PFO closure Among patients aged 18–65 who have had a cryptogenic ischemic…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline